Skip to main content

Teradyne Inc. (Friday’s close US$44.03) traded within a wide horizontal trading range mostly between US$9 and US$22 for about 13 years (dashed lines – partly shown). The stock started a new up-leg in 2016 when it broke above the top of this range and reached a high of US$50.68 in March, 2018 (A).

A corrective period followed during 2018 as the stock traded within a falling channel (dotted lines) and found support near ±US$30 (B). The recent rise above the top of this channel signalled the resumption of the up-trend (C).

Teradyne recently had a correction (D) and now appears ready to resume the up-trend. Only a sustained decline below US$38-39 would be negative.

Story continues below advertisement

Point & Figure measurements provide targets of US$49 and US$54. Significantly higher targets are visible.

rb-gi-meisels-0615

?

Monica Rizk is the senior Technical Analyst and Ron Meisels is the president of Phases & Cycles Inc. (www.phases-cycles.com). And he tweets at @Ronsbriefs. They may hold shares in companies profiled.

Chart source: www.decisionplus.com

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter